Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8943)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2019 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu F, Li YM, Feng TT, Wu Y, Zhang HX, Jin GY, Liu JP. Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(24): 3056-3068 [PMID: 31293341 DOI: 10.3748/wjg.v25.i24.3056] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i24/3056.htm |
| Number | Citing Articles |
| 1 |
Qi Shao, Yiping Wu, Jing Ji, Tian Xu, Qiaoyu Yu, Chongyang Ma, Xuejing Liao, Fafeng Cheng, Xueqian Wang. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Frontiers in Psychiatry 2021; 12 doi: 10.3389/fpsyt.2021.711835
|
| 2 |
Zhi-Tong Zhang, Wen-Jiao He, Si-Min Deng, Shu-Hong Xu, Xia Zeng, Zheng-Ming Qian, Zhi-Quan Chen, Shu-Mei Wang, Dan Tang. Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation. European Journal of Pharmacology 2022; 933: 175291 doi: 10.1016/j.ejphar.2022.175291
|
| 3 |
Jian-Hong Ding, Zhe Jin, Xiao-Xu Yang, Jun Lou, Wei-Xi Shan, Yan-Xia Hu, Qian Du, Qiu-Shi Liao, Rui Xie, Jing-Yu Xu. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World Journal of Gastroenterology 2020; 26(40): 6141-6162 doi: 10.3748/wjg.v26.i40.6141
|
| 4 |
Tian Lan, Xiao-juan Geng, Si-jia Zhang, Xi-xi Zeng, Jun-jie Ying, Yi Xu, Shi-yu Liu, Ping Li, Yu-hua Tong, Wen Wang, Zhu-jun Mao, Si-wei Wang. Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis. Phytomedicine 2024; 123: 155209 doi: 10.1016/j.phymed.2023.155209
|
| 5 |
Xu Yang, Junqi Zhang, Yanghao Li, Huiting Hu, Xiang Li, Tonghui Ma, Bo Zhang. Si–Ni-San promotes liver regeneration by maintaining hepatic oxidative equilibrium and glucose/lipid metabolism homeostasis. Journal of Ethnopharmacology 2024; 326: 117918 doi: 10.1016/j.jep.2024.117918
|
| 6 |
Anhui Wang, Xue Yang, Jiachun Lin, Yali Wang, Jinni Yang, Yuting Zhang, Yuan Tian, Haijuan Dong, Zunjian Zhang, Rui Song. Si-Ni-San alleviates intestinal and liver damage in ulcerative colitis mice by regulating cholesterol metabolism. Journal of Ethnopharmacology 2025; 336: 118715 doi: 10.1016/j.jep.2024.118715
|
| 7 |
Kangning Zheng, Wenhan Zhou, Jingmin Ji, Yu Xue, Yiwei Liu, Caige Li, Zhiqin Zhang, Junlan Lu, Xinli Shi, Yongmin Li. Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction–associated fatty liver disease. Journal of Ethnopharmacology 2023; 305: 116081 doi: 10.1016/j.jep.2022.116081
|
| 8 |
Min Liu, Wei Shi, Yefang Huang, Yeke Wu, Keming Wu. Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1134430
|
| 9 |
Yuan Ma, Kewei Sun, Jianzhong Cao, Xiaowu Qin, Jiaoling Shi, Huiying Li, Jun Zhang, Tao Zhang. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease. Medicine 2021; 100(51): e28083 doi: 10.1097/MD.0000000000028083
|
| 10 |
Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li. Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge. Acta Pharmaceutica Sinica B 2022; 12(9): 3529 doi: 10.1016/j.apsb.2022.05.001
|
| 11 |
Ning Zhang, Tong Liu, Jianan Wang, Yingying Xiao, Ying Zhang, Jun Dai, Zhihong Ma, Donglai Ma. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. Drug Design, Development and Therapy 2023; : 3047 doi: 10.2147/DDDT.S417378
|
| 12 |
Xiaoyi Wei, Weixin Hou, Jiajun Liang, Peng Fang, Bo Dou, Zisong Wang, Jiayang Sai, Tian Xu, Chongyang Ma, Qiuyun Zhang, Fafeng Cheng, Xueqian Wang, Qingguo Wang. Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.693701
|
| 13 |
Hang Chu, Weitao Zhang, Yan Tan, Zhipeng Diao, Peng Li, Yapeng Wu, Like Xie, Jianguo Sun, Ke Yang, Pingping Li, Cen Xie, Ping Li, Qian Hua, Xiaojun Xu. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction. Journal of Ethnopharmacology 2023; 317: 116665 doi: 10.1016/j.jep.2023.116665
|
| 14 |
Yanwei LI, Yunrui LU, Mozuo NIAN, Qiuju SHENG, Chong ZHANG, Chao HAN, Xiaoguang DOU, Yang DING. Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease. Chinese Journal of Natural Medicines 2023; 21(9): 643 doi: 10.1016/S1875-5364(23)60443-1
|
| 15 |
Qiong Wu, Fangsi Zhu, Yu Yao, Luyun Chen, Yijie Ding, Yong Su, Chaoliang Ge. Sini san regulates intestinal flora and short-chain fatty acids to ameliorate hepatocyte apoptosis and relieve CCl4-induced liver fibrosis in mice. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1408459
|
| 16 |
Jianchao Li, Kaiyi Wu, Ying Zhong, Jiangying Kuang, Nana Huang, Xin Guo, Hang Du, Chong Guo, Rongrong Li, Xiaomin Zhu, Tianyu Zhang, Liping Gong, Lisong Sheng, Rong Sun. Si–Ni-SAN ameliorates obesity through AKT/AMPK/HSL pathway-mediated lipolysis: Network pharmacology and experimental validation. Journal of Ethnopharmacology 2023; 302: 115892 doi: 10.1016/j.jep.2022.115892
|
| 17 |
Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su. Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572729
|
| 18 |
Qiwei Liu, Yunwen Xue, Jingjing Liu, Siqi Ren, Jie Xu, Jinni Yang, Yuanyue Xing, Zunjian Zhang, Rui Song. Saikosaponins and the deglycosylated metabolites exert liver meridian guiding effect through PXR/CYP3A4 inhibition. Journal of Ethnopharmacology 2021; 279: 114344 doi: 10.1016/j.jep.2021.114344
|
| 19 |
Yajie Cai, Xiaojiaoyang Li, Qi Han, Jinzhao Bai, Qi Zheng, Rong Sun, Runping Liu. Si–Ni-San improves experimental colitis by favoring Akkermensia colonization. Journal of Ethnopharmacology 2023; 305: 116067 doi: 10.1016/j.jep.2022.116067
|
| 20 |
Siliang Wang, Cheng Tang, Heng Zhao, Peiliang Shen, Chao Lin, Yun Zhu, Dan Han. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.656115
|
| 21 |
Kai Yu, Kai Huang, Shisong Jiang, Xiao Tang, Xiuyun Huang, Linlin Sun, Linxing Pang, Cuiqin Mo. Protective function on liver and proteomic analysis of the improvement mechanism of Sedum sarmentosum Bunge extract on nonalcoholic fatty liver disease in Nile tilapia. Aquaculture 2021; 531: 735977 doi: 10.1016/j.aquaculture.2020.735977
|
| 22 |
Xiaoying Xu, Huimei Hu, Haizhou Zeng, Boyi Li, Qiuxiong Yin, Yupeng Jiang, Linquan Zang, Changlin Zhao, Guoqiang Qian. Sinisan ameliorates colonic injury induced by water immersion restraint stress by enhancing intestinal barrier function and the gut microbiota structure. Pharmaceutical Biology 2023; 61(1): 598 doi: 10.1080/13880209.2023.2191643
|